ArticleTargeted oncology2022

Pembrolizumab in Combination with Chemotherapy in Patients with ERBB2-Mutated Non-Small Cell Lung Cancer.

Fawzi Abu Rous et al.PubMed ↗Publisher ↗

No numbers read from the abstract.